Atherogenic Index of Plasma (AIP) a Tool to Assess Changes in Cardiovascular Disease Risk Post Laparoscopic Sleeve Gastrectomy

Table 2

Clinical characteristics of the morbid-obese participants baseline, 6-month, and 1-year post-LSG.

Variable	Morbid obese with T2D			Morbid obese without T2D
	Baseline; ()	6 months; ()	1 year; ()	Baseline; ()	6 months; ()	1 year; ()
BMI (kg/m^2)
EBL (%)	—			—
EWL (%)	—			—
Body fat (%)
VFA (cm^2)
SBP (mmHg)
DBP (mmHg)
Vascular age (year)
TC (mM)
TG (mM)	1.84 (1.09-2.8)	0.98 (0.7-1.4)	1.14 (0.6-1.2)	0.88 (0.7-1.7)	0.76 (0.6-1.01)	0.58 (0.44-1)
LDL (mM)
HDL (mM)
VLDL (mM)
oxLDL (mg/mL)
AIP (log TG/HDL)
hsCRP (mg/dl)
Insulin (pg/mL)
c-peptide (pg/mL)
FPG (mM)
A1c (%)
ALT (IU/L)	40 (37-53)	31 (28-34)	34 (29-38)	39 (32.5-53)	31 (27-34)	29 (27-39)
AST (IU/L)	23 (17-28)	15 (12-19)	18 (16-25)	18 (15.5-27)	18 (14.5-19)	13 (10-19)

Baseline, 6 months, and 1-year post-LSG data are presented as , or median with interquartile. Analysis of variance (ANOVA) (unpaired analysis) with post hoc Bonferroni test for multiple comparisons was used to determine significant change post-LSG in diabetic and nondiabetic morbid-obese subjects, value ≤0.05 was considered significant. (), and value <0.01 indicates highly significant values (). VFA: visceral fat area; %EWL: percent excess weight loss; %EBL: percent of excess BMI loss.